Drug choice to lowering risk contiguity with Morbus Hansen disease: A review article

Gofur, Nanda Rachmad Putra; Gofur, Aisyah Rachmadani Putri; Putri, Hernalia Martadila; Soesilaningtyas, Soesilaningtyas; Halimah, Annisa Nur; Feriana, Dwiyanti; Rusdiana, Elly; Wahjuni, Sri; Rosa, Mia Laksmi Lita; Yusof, Zamros Yuzadi Bin Mohd

doi:10.51847/cksxmt6vsy

J Adv Pharm Educ Res

2023

DOI: 10.51847/cksxmt6vsy

|View full text |Cite

Drug choice to lowering risk contiguity with Morbus Hansen disease: A review article

Nanda Rachmad Putra Gofur¹,

Aisyah Rachmadani Putri Gofur²,

Hernalia Martadila Putri³

et al.

Abstract: This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

From Challenges to Solution: The Evolving Landscape of Leprosy Management

Moreira,

Oliveira,

Chaves

et al. 2024

Advanced Therapeutics

View full text Add to dashboard Cite

Leprosy, caused by Mycobacterium leprae, despite being a curable disease when treated can induce peripheral neuropathy. However, the medicines used in polychemotherapy promote several side effects. Thus, research for the development of new administration systems is an alternative, but there is a lack of preclinical and clinical studies of the systems, where 90.90% have a level of technological maturity 3 and 9.09% level 4. The main issues are associated with deficiencies in vitro and in vivo cultivation methodologies, lack of financing, as well as the disinterest of the pharmaceutical industry in investing in neglected tropical diseases. In addition, with the emergence of resistant bacteria, there is urgency in the search for vaccines and, therefore, in the expansion of immunomodulation studies to define the molecular targets of the vaccine and future medications. In addition, future treatments for various diseases, including leprosy, will be directly influenced by the evolution of additive manufacturing and 3D printing, seeking personalized, flexible, and reproducible treatment.

show abstract

From Challenges to Solution: The Evolving Landscape of Leprosy Management

Moreira,

Oliveira,

Chaves

et al. 2024

Advanced Therapeutics

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Drug choice to lowering risk contiguity with Morbus Hansen disease: A review article

Cited by 1 publication

References 24 publications

From Challenges to Solution: The Evolving Landscape of Leprosy Management

From Challenges to Solution: The Evolving Landscape of Leprosy Management

Contact Info

Product

Resources

About